A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx

44:49
 
Share
 

Manage episode 291481405 series 2738732
By Greg Kubin & Matias Serebrinsky, Greg Kubin, and Matias Serebrinsky. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Today's episode features Deborah Mash, founder and CEO of DemeRx, a clinical stage company developing ibogaine therapies to treat substance use disorders.

In this episode, we discuss:

  • The science, experience and the safety behind Ibogaine’s “neurochemical reset”
  • Navigating US drug regulatory system and securing Intellectual Property
  • Deborah’s 30 journey through Amsterdam, Miami and the Caribbean aiming to get Ibogaine therapy approved
  • Partnership with ATAI Life Sciences

Links to topics discussed in this episode:
Deborah Mash
DemeRx
Ibogaine
Noribogaine
Tabernanthe Iboga
Bwiti Religion
Howard Lotsof
Serotonergics
Lambarene - promoted as a mental and physical stimulant
Habenula
Addiction Expert Gabor Maté
Read the transcript here.
Watch episode 8 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh

Find us at businesstrip.fm
Follow us on Instagram and Twitter!

Theme music by Dorian Love
Additional music by Medita by Crowander, Two Feet by Muted Circus, and Rain On Me by JBlanked.

20 episodes